NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Stem cell hype: Join the conversation

Posted By

Michael Joyce is a multimedia producer at and tweets as @mlmjoyce

Ten years ago this probably wouldn’t even have been a topic of conversation.

If it had, it likely would have been about medical tourism. There would’ve been outrage directed at “third world” countries who allow unregulated and unproven stem cell “therapies” to be offered to desperate patients.

Well, that concern is now closer to home.

There are now hundreds of such clinics across the U.S. The number of clinics is growing, more people are being hurt, state and federal oversight is shockingly inadequate, and the question has become urgent: What can we do about it?

That’s precisely why we produced a recent podcast and sought out the perspectives of these people:

  • George Gibson, a patient left blind after a dubious stem cell intervention
  • Leigh Turner PhD, a bioethicist who’s been following the stem cell marketplace closely
  • Drs. Jeanne Loring and Paul Knoepfler – two PhD stem cell researchers from California 

It’s also why we’re hosting a Tweet chat about stem cells that will bring together journalists, stem cell researchers, ethicists, and hopefully many patients and family members.

The chat will be held on Wednesday, August 9 from 2 to 3 p.m. EDT under the hashtag #stemcellhype.

Questions we’ll be discussing during the chat include:

  • What is #stemcellhype? Can you share examples from news stories/PR/marketing in your area?
  • What are the harms of #stemcellhype? Why does this matter to patients and the public?
  • What advice can we give consumers trying to tell legitimate from non-legitimate stem cell therapies?
  • Stopping #stemcellhype: Where do we start? FDA? FTC? Medical boards? Journalism?

Stem cell therapies — when properly researched and applied — hold great promise. That makes it all the more critical to openly discuss stem cell interventions that are not evidence-based, not regulated, promoted in misleading ways, and have the potential to cause harm.

Please join the conversation!

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.